Radiotherapy is a remedy for cancer which makes use of beams of excessive power radiation to kill cancer tissues in the body. This therapy stops most cancers cells from multiplying. Also referred to as radiation remedy, radiotherapy is rising as a primary technology for killing the most cancers disorder. The global radiotherapy marketplace is an extensively developing sector in latest years. Radiotherapy is use of excessive electricity radiation from x-rays, gamma rays, neutrons, protons, and other sources to shrink tumors, kill cancer cells and repair distinct physiological abnormalities. Approximately 70% of the cancer sufferers globally undergo a few or different form of radiotherapy at some point of their direction of remedy. Moreover, 20% of malignant tumors face up to radiation; subsequently neutron based radiation therapy is used as an alternative for traditional radiation because of its extreme ionizing property. The major devices are digital mammography & ultrasound structures, computed tomography structures, intraoperative x-ray (fluoroscopic) guidance, magnetic resonance and positron emission tomography – ct (pet-ct)
How Big is the Global Radiotherapy Devices Market?
The Global Radiotherapy Devices Market is expected to be around US$ 10 Billion by 2028 and will grow at a CAGR of more than 6% in the given forecast period..
The major driving factors of Global Radiotherapy Devices Market are as follows:
• Rising number of cancer patients
• Rapidly changing cancer treatment technology
• Emerging healthy reimbursement
The restraining factors of Global Radiotherapy Devices Market are as follows:
• Need adequate infrastructure
• Healthcare expenditure
• Need adequate skills and training.
• Alternative treatment procedures
The Global Radiotherapy Devices Market is segmented on the lines of its type, technology, application and regional. Each these segments are further classified into external beam radiation therapy, internal beam radiation therapy and systemic radiation therapy. Based on technology segmentation the external beam radiation therapy is classified into image guided radio therapy, 3-D conformal radiotherapy, intensity modulated radiation therapy, tomotherapy, adaptive radiation therapy and others. Internal beam radiation therapy covers low dose rate and high dose rate. Based on application segment the external beam radiation therapy is classified into prostate cancer, head and neck cancer, breast cancer, spine cancer, lung cancer and brain cancer. Internal beam radiation therapy covers gynecological cancer, esophageal cancer, penile cancer and cervical cancer. The Global Radiotherapy Devices Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Radiotherapy Devices and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Radiotherapy Devices Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for Global Radiotherapy Devices Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Varian Medical System, Accuray, Inc., Elekta AB, and IsoRay Medical, Inc. Other players include IBA Group (Belgium), Eckert & Ziegler BEBIG (Belgium), iCAD, Inc. (U.S.), GE Healthcare (U.K.), Covidien, PLC (Ireland), C.R. Bard, Inc. (U.S.), Nordion, Inc. (Canada), Theragenics Corporation (U.S.), Oncura, Inc. (U.S.).Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Radiotherapy Devices Market has been segmented as below:
By Type Analysis
• External beam radiation therapy
• Internal radiation therapy
• Systemic radiation therapy
By Technology Analysis
• External beam radiation therapy
o Image guided radio therapy
o 3-D conformal radiotherapy
o Intensity modulated radiation therapy
o Tomotherapy
o Adaptive radiation therapy
o Others
• Internal beam radio therapy
o Low dose rate
o High dose rate
• Systemic radiation therapy.
By Application Analysis
• External beam radiation therapy
o Prostate cancer
o Head and neck cancer
o Breast cancer
o Spine cancer
o Lung cancer
o Brain cancer
• Internal radiation therapy
o Gynecological cancer
o Esophageal cancer
o Penile cancer
o Cervical cancer
• Systemic radiation therap
By Regional Analysis
• North America
• Europe
• Asia-Pacific
• Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Radiotherapy Devices Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Radiotherapy Devices Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.2.1.1 Bottom-Up Approach
2.2.1.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion
4 Premium Insights
4.1 Global Market (2015–2020)
4.2 Global Market Size, By Product (2015 vs 2020)
4.3 External Beam Radiation Therapy Market, By Technology (2015 vs 2020)
4.4 Global Market Size, By Application (2015)
5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.2.1 Radiotherapy Market, By Product
5.2.2 Radiotherapy Market, By Technology
5.2.3 Radiotherapy Market, By Application
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Technological Advancements
5.3.1.2 Growing Number of Cancer Patients
5.3.1.3 Rapidly Increasing Aging Population
5.3.1.4 Rising Adoption of Radiotherapy Devices and Procedures
5.3.1.5 Increasing Number of Symposiums Spreading Awareness About the Benefits of Radiotherapy
5.3.2 Restraints
5.3.2.1 Lack of Adequate Infrastructure & Healthcare Expenditure
5.3.2.2 Shortage of Trained Personnel
5.3.2.3 Unfavourable Healthcare Reforms in the United States
5.3.3 Opportunities
5.3.3.1 Emerging Markets Offer Numerous Growth Opportunities
5.3.3.2 Increasing Demand for Cancer Treatment Driving Investments in Radiotherapy
5.3.4 Challenges
5.3.4.1 Difficulty in Visualizing Tumors
5.3.4.2 Affordability and Accessibility of Treatment
6 Radiotherapy Market, By Product
6.1 Introduction
6.2 External Beam Radiation Therapy
6.2.1 Introduction
6.2.2 Electron-Emitting High-Energy Linear Accelerators (Linac)
6.2.3 Compact Advanced Radiotherapy Systems
6.2.3.1 Introduction
6.2.3.2 Cyberknife
6.2.3.3 Gamma Knife
6.2.3.4 Tomotherapy
6.2.4 Proton Therapy Systems
6.2.4.1 Cyclotron
6.2.4.2 Synchrotron
6.3 Internal Radiation Therapy
6.3.1 Introduction
6.3.2 Seeds
6.3.3 Applicators and Afterloaders
6.3.4 Electronic Brachytherapy
6.4 Systemic Radiation Therapy
7 Radiotherapy Market, By Technology
7.1 Introduction
7.2 External Beam Radiation Therapy
7.2.1 Introduction
7.2.2 Image-Guided Radiotherapy (IGRT)
7.2.3 Intensity Modulated Radiotherapy (IMRT)
7.2.4 Stereotactic Technology
7.2.5 Particle/Proton Beam Therapy
7.2.6 Tomotherapy
7.2.7 3D-Conformal Radiotherapy (3D-CRT)
7.2.8 Volumetric Modulated ARC Therapy
7.3 Internal Beam Radiation Therapy
7.3.1 Introduction
7.3.2 Low-Dose Rate Radiotherapy
7.3.3 High Dose Rate Radiotherapy
7.4 Systemic Radiation Therapy
8 Global Radiotherapy Market, By Application
8.1 Introduction
8.2 External Beam Radiation Therapy
8.2.1 Introduction
8.2.2 Prostate Cancer
8.2.3 Breast Cancer
8.2.4 Lung Cancer
8.2.5 Head and Neck Cancer
8.2.6 Colorectal Cancer
8.2.7 Others
8.3 Internal Radiation Therapy/Brachytherapy
8.3.1 Introduction
8.3.2 Prostate Cancer
8.3.3 Gynecological Cancer
8.3.4 Breast Cancer
8.3.5 Cervical Cancer
8.3.6 Penile Cancer
8.3.7 Others
9 Radiotherapy Market, By Region
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia-Pacific
9.5 Rest of the World (RoW)
9.5.1 Latin America
9.5.2 Middle East
9.5.3 Africa
10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Situation and Trends
10.3.1 New Product Launches and Product Enhancements
10.3.2 Agreements, Partnerships, Collaborations, and Contracts
10.3.3 Mergers and Acquisitions
10.3.4 Geographic Expansions
10.3.5 Other Developments
The Global Radiotherapy Devices Market has been segmented as below:
By Type Analysis
• External beam radiation therapy
• Internal radiation therapy
• Systemic radiation therapy
By Technology Analysis
• External beam radiation therapy
o Image guided radio therapy
o 3-D conformal radiotherapy
o Intensity modulated radiation therapy
o Tomotherapy
o Adaptive radiation therapy
o Others
• Internal beam radio therapy
o Low dose rate
o High dose rate
• Systemic radiation therapy.
By Application Analysis
• External beam radiation therapy
o Prostate cancer
o Head and neck cancer
o Breast cancer
o Spine cancer
o Lung cancer
o Brain cancer
• Internal radiation therapy
o Gynecological cancer
o Esophageal cancer
o Penile cancer
o Cervical cancer
• Systemic radiation therapy
By Regional Analysis
• North America
• Europe
• Asia-Pacific
• Rest of the World
SUBSCRIBE TO OUR NEWSLETTERS
